Responses
Oral Presentations
Progress in biological treatment of RA
OP0104 Tocilizumab: dose reduction or interval spacing – which proves a better tapering strategy for rheumatoid arthritis in clinical remission?
Compose a Response to This Article
Other responses
No responses have been published for this article.